CIK: 0001703031
Total reported value
$1.1B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | HTFL | Heartflow INC | Stock-Other | 27.81% | -4.86% | — | |
| 2 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 20.23% | +1.46% | — | |
| 3 | CDTX | Cidara Therapeutics INC | Stock-Other | 19.20% | — | +20.81% | |
| 4 | PHVS | Pharvaris N.V. | Stock-Other | 5.27% | +0.86% | -3.70% | |
| 5 | OLMA | Olema Pharmaceuticals INC | Stock-Other | 4.45% | -6.24% | — | |
| 6 | SVRA | Savara INC | Stock-Other | 4.17% | +0.54% | — | |
| 7 | DNTH | Dianthus Therapeutics INC | Stock-Other | 3.44% | +0.39% | -46.99% | |
| 8 | SLDB | Solid Biosciences INC | Stock-Other | 3.24% | +2.95% | — | |
| 9 | UPB | Upstream Bio INC | Stock-Other | 3.05% | -2.06% | — | |
| 10 | RPID | Rapid Micro Biosystems Inc-a | Stock-Other | 1.87% | -0.14% | — | |
| 11 | TNGX | Tango Therapeutics INC | Stock-Other | 1.51% | -0.44% | EXIT | |
| 12 | CABA | Cabaletta Bio INC | Stock-Other | 1.50% | +0.73% | — | |
| 13 | KYTX | Kyverna Therapeutics INC | Stock-Other | 1.34% | +0.18% | — | |
| 14 | ANNX | Annexon INC | Stock-Other | 1.06% | +0.58% | — | |
| 15 | XFOR | X4 Pharmaceuticals INC | Stock-Other | 0.55% | +0.53% | +332.13% | |
| 16 | AVIR | Atea Pharmaceuticals INC | Stock-Other | 0.48% | +0.47% | — | |
| 17 | ✓ | Xilio Therapeutics INC | Stock-Other | 0.26% | -0.36% | EXIT | |
| 18 | MRSN | Mersana Therapeutics INC | Stock-Other | 0.18% | -0.77% | EXIT | |
| 19 | CCCC | C4 Therapeutics INC | Stock-Other | 0.16% | +0.65% | — | |
| 20 | IPSC | Century Therapeutics INC | Stock-Other | 0.12% | — | -34.60% | |
| 21 | ✓ | Newamsterdam Pharma Company | Stock-Other | 0.11% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CDTX | Cidara Therapeutics INC | +17% | +20.81% | Add |
| 2 | UPB | Upstream Bio INC | +1% | — | Add |
| 3 | TNGX | Tango Therapeutics INC | +1% | — | Unchanged |
| 4 | CABA | Cabaletta Bio INC | +0.9% | — | Add |
| 5 | OLMA | Olema Pharmaceuticals INC | +0.6% | — | Unchanged |
| 6 | KYTX | Kyverna Therapeutics INC | +0.4% | — | Unchanged |
| 7 | ✓ | Newamsterdam Pharma Company | 0% | — | Unchanged |
| 8 | CCCC | C4 Therapeutics INC | -0.1% | — | Unchanged |
| 9 | ✓ | Xilio Therapeutics INC | -0.2% | — | Unchanged |
| 10 | IPSC | Century Therapeutics INC | -0.3% | -34.60% | Trim |
| 11 | ANNX | Annexon INC | -0.4% | — | Unchanged |
| 12 | AVIR | Atea Pharmaceuticals INC | -0.6% | — | Unchanged |
| 13 | SLDB | Solid Biosciences INC | -1.1% | — | Unchanged |
| 14 | RPID | Rapid Micro Biosystems Inc-a | -1.4% | — | Unchanged |
| 15 | PHVS | Pharvaris N.V. | -2.4% | -3.70% | Trim |
| 16 | SVRA | Savara INC | -3% | — | Unchanged |
| 17 | DNTH | Dianthus Therapeutics INC | -3.8% | -46.99% | Trim |
| 18 | NAMS | NewAmsterdam Pharma Company N.V. | -12.2% | — | Unchanged |
| 19 | HTFL | Heartflow INC | — | NEW | New buy |
| 20 | NUVL | Nuvalent Inc-a | — | EXIT | Sold out |
| 21 | IRON | Disc Medicine INC | — | EXIT | Sold out |
| 22 | XFOR | X4 Pharmaceuticals INC | — | NEW | New buy |
| 23 | ASNSUSD | X4 Pharmaceuticals INC | — | EXIT | Sold out |
| 24 | ✓ | Mersana Therapeutics INC | — | EXIT | Sold out |
| 25 | MRSN | Mersana Therapeutics INC | — | NEW | New buy |
| 26 | IVVD | Invivyd INC | — | EXIT | Sold out |
| 27 | NAUT | Nautilus Biotechnology INC | — | EXIT | Sold out |